nodes	percent_of_prediction	percent_of_DWPC	metapath
Rasagiline—Parkinson's disease—Bromocriptine—type 2 diabetes mellitus	0.387	1	CpDpCtD
Rasagiline—BCL2—type 2 diabetes mellitus	0.27	0.735	CbGaD
Rasagiline—CYP1A2—type 2 diabetes mellitus	0.0974	0.265	CbGaD
Rasagiline—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0248	0.329	CbGbCtD
Rasagiline—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0195	0.259	CbGbCtD
Rasagiline—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0185	0.245	CbGbCtD
Rasagiline—CYP1A2—Losartan—type 2 diabetes mellitus	0.0126	0.167	CbGbCtD
Rasagiline—Vomiting—Sitagliptin—type 2 diabetes mellitus	5.15e-05	0.000446	CcSEcCtD
Rasagiline—Constipation—Gliclazide—type 2 diabetes mellitus	5.15e-05	0.000445	CcSEcCtD
Rasagiline—Tremor—Losartan—type 2 diabetes mellitus	5.13e-05	0.000444	CcSEcCtD
Rasagiline—Rash—Glimepiride—type 2 diabetes mellitus	5.13e-05	0.000443	CcSEcCtD
Rasagiline—Dermatitis—Glimepiride—type 2 diabetes mellitus	5.12e-05	0.000443	CcSEcCtD
Rasagiline—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	5.12e-05	0.000443	CcSEcCtD
Rasagiline—Rash—Sitagliptin—type 2 diabetes mellitus	5.11e-05	0.000442	CcSEcCtD
Rasagiline—Dermatitis—Sitagliptin—type 2 diabetes mellitus	5.1e-05	0.000442	CcSEcCtD
Rasagiline—Headache—Glimepiride—type 2 diabetes mellitus	5.09e-05	0.000441	CcSEcCtD
Rasagiline—Ill-defined disorder—Losartan—type 2 diabetes mellitus	5.09e-05	0.00044	CcSEcCtD
Rasagiline—Cough—Irbesartan—type 2 diabetes mellitus	5.08e-05	0.00044	CcSEcCtD
Rasagiline—Headache—Sitagliptin—type 2 diabetes mellitus	5.08e-05	0.000439	CcSEcCtD
Rasagiline—Anaemia—Losartan—type 2 diabetes mellitus	5.07e-05	0.000438	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	5.04e-05	0.000436	CcSEcCtD
Rasagiline—Agitation—Losartan—type 2 diabetes mellitus	5.04e-05	0.000436	CcSEcCtD
Rasagiline—Hypertension—Irbesartan—type 2 diabetes mellitus	5.03e-05	0.000435	CcSEcCtD
Rasagiline—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	5.02e-05	0.000434	CcSEcCtD
Rasagiline—Infection—Metformin—type 2 diabetes mellitus	5e-05	0.000433	CcSEcCtD
Rasagiline—Insomnia—Valsartan—type 2 diabetes mellitus	5e-05	0.000433	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	4.98e-05	0.000431	CcSEcCtD
Rasagiline—Paraesthesia—Valsartan—type 2 diabetes mellitus	4.97e-05	0.00043	CcSEcCtD
Rasagiline—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	4.96e-05	0.000429	CcSEcCtD
Rasagiline—Arthralgia—Irbesartan—type 2 diabetes mellitus	4.96e-05	0.000429	CcSEcCtD
Rasagiline—Chest pain—Irbesartan—type 2 diabetes mellitus	4.96e-05	0.000429	CcSEcCtD
Rasagiline—Shock—Metformin—type 2 diabetes mellitus	4.96e-05	0.000429	CcSEcCtD
Rasagiline—Insomnia—Orlistat—type 2 diabetes mellitus	4.94e-05	0.000428	CcSEcCtD
Rasagiline—Malaise—Losartan—type 2 diabetes mellitus	4.94e-05	0.000428	CcSEcCtD
Rasagiline—Anxiety—Irbesartan—type 2 diabetes mellitus	4.94e-05	0.000427	CcSEcCtD
Rasagiline—Hypersensitivity—Glyburide—type 2 diabetes mellitus	4.94e-05	0.000427	CcSEcCtD
Rasagiline—Nervous system disorder—Metformin—type 2 diabetes mellitus	4.94e-05	0.000427	CcSEcCtD
Rasagiline—Dyspnoea—Valsartan—type 2 diabetes mellitus	4.93e-05	0.000427	CcSEcCtD
Rasagiline—Vertigo—Losartan—type 2 diabetes mellitus	4.92e-05	0.000426	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	4.92e-05	0.000426	CcSEcCtD
Rasagiline—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	4.92e-05	0.000426	CcSEcCtD
Rasagiline—Somnolence—Valsartan—type 2 diabetes mellitus	4.92e-05	0.000425	CcSEcCtD
Rasagiline—Syncope—Losartan—type 2 diabetes mellitus	4.91e-05	0.000425	CcSEcCtD
Rasagiline—Paraesthesia—Orlistat—type 2 diabetes mellitus	4.91e-05	0.000425	CcSEcCtD
Rasagiline—Leukopenia—Losartan—type 2 diabetes mellitus	4.91e-05	0.000424	CcSEcCtD
Rasagiline—Discomfort—Irbesartan—type 2 diabetes mellitus	4.9e-05	0.000424	CcSEcCtD
Rasagiline—Skin disorder—Metformin—type 2 diabetes mellitus	4.89e-05	0.000423	CcSEcCtD
Rasagiline—Immune system disorder—Ramipril—type 2 diabetes mellitus	4.88e-05	0.000422	CcSEcCtD
Rasagiline—Hyperhidrosis—Metformin—type 2 diabetes mellitus	4.87e-05	0.000421	CcSEcCtD
Rasagiline—Dyspepsia—Valsartan—type 2 diabetes mellitus	4.87e-05	0.000421	CcSEcCtD
Rasagiline—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	4.87e-05	0.000421	CcSEcCtD
Rasagiline—Dizziness—Bromocriptine—type 2 diabetes mellitus	4.85e-05	0.00042	CcSEcCtD
Rasagiline—Dry mouth—Irbesartan—type 2 diabetes mellitus	4.85e-05	0.00042	CcSEcCtD
Rasagiline—Nausea—Glimepiride—type 2 diabetes mellitus	4.83e-05	0.000418	CcSEcCtD
Rasagiline—Loss of consciousness—Losartan—type 2 diabetes mellitus	4.82e-05	0.000417	CcSEcCtD
Rasagiline—Nausea—Sitagliptin—type 2 diabetes mellitus	4.81e-05	0.000416	CcSEcCtD
Rasagiline—Dyspepsia—Orlistat—type 2 diabetes mellitus	4.81e-05	0.000416	CcSEcCtD
Rasagiline—Asthenia—Glyburide—type 2 diabetes mellitus	4.81e-05	0.000416	CcSEcCtD
Rasagiline—Decreased appetite—Valsartan—type 2 diabetes mellitus	4.81e-05	0.000416	CcSEcCtD
Rasagiline—Anorexia—Metformin—type 2 diabetes mellitus	4.8e-05	0.000415	CcSEcCtD
Rasagiline—Cough—Losartan—type 2 diabetes mellitus	4.78e-05	0.000414	CcSEcCtD
Rasagiline—Urticaria—Gliclazide—type 2 diabetes mellitus	4.78e-05	0.000414	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	4.77e-05	0.000413	CcSEcCtD
Rasagiline—Alopecia—Ramipril—type 2 diabetes mellitus	4.77e-05	0.000413	CcSEcCtD
Rasagiline—Abdominal pain—Gliclazide—type 2 diabetes mellitus	4.76e-05	0.000412	CcSEcCtD
Rasagiline—Body temperature increased—Gliclazide—type 2 diabetes mellitus	4.76e-05	0.000412	CcSEcCtD
Rasagiline—Decreased appetite—Orlistat—type 2 diabetes mellitus	4.75e-05	0.000411	CcSEcCtD
Rasagiline—Pruritus—Glyburide—type 2 diabetes mellitus	4.74e-05	0.00041	CcSEcCtD
Rasagiline—Mental disorder—Ramipril—type 2 diabetes mellitus	4.73e-05	0.000409	CcSEcCtD
Rasagiline—Constipation—Valsartan—type 2 diabetes mellitus	4.73e-05	0.000409	CcSEcCtD
Rasagiline—Infection—Irbesartan—type 2 diabetes mellitus	4.72e-05	0.000409	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	4.72e-05	0.000408	CcSEcCtD
Rasagiline—Hypotension—Metformin—type 2 diabetes mellitus	4.71e-05	0.000407	CcSEcCtD
Rasagiline—Malnutrition—Ramipril—type 2 diabetes mellitus	4.7e-05	0.000407	CcSEcCtD
Rasagiline—Shock—Irbesartan—type 2 diabetes mellitus	4.68e-05	0.000405	CcSEcCtD
Rasagiline—Arthralgia—Losartan—type 2 diabetes mellitus	4.67e-05	0.000404	CcSEcCtD
Rasagiline—Chest pain—Losartan—type 2 diabetes mellitus	4.67e-05	0.000404	CcSEcCtD
Rasagiline—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.66e-05	0.000403	CcSEcCtD
Rasagiline—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	4.66e-05	0.000403	CcSEcCtD
Rasagiline—Anxiety—Losartan—type 2 diabetes mellitus	4.65e-05	0.000402	CcSEcCtD
Rasagiline—Rash—Bromocriptine—type 2 diabetes mellitus	4.62e-05	0.0004	CcSEcCtD
Rasagiline—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.62e-05	0.0004	CcSEcCtD
Rasagiline—Skin disorder—Irbesartan—type 2 diabetes mellitus	4.62e-05	0.000399	CcSEcCtD
Rasagiline—Discomfort—Losartan—type 2 diabetes mellitus	4.61e-05	0.000399	CcSEcCtD
Rasagiline—Dysgeusia—Ramipril—type 2 diabetes mellitus	4.6e-05	0.000398	CcSEcCtD
Rasagiline—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	4.59e-05	0.000398	CcSEcCtD
Rasagiline—Headache—Bromocriptine—type 2 diabetes mellitus	4.59e-05	0.000397	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.59e-05	0.000397	CcSEcCtD
Rasagiline—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.59e-05	0.000397	CcSEcCtD
Rasagiline—Dry mouth—Losartan—type 2 diabetes mellitus	4.56e-05	0.000395	CcSEcCtD
Rasagiline—Anorexia—Irbesartan—type 2 diabetes mellitus	4.53e-05	0.000392	CcSEcCtD
Rasagiline—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.52e-05	0.000391	CcSEcCtD
Rasagiline—Paraesthesia—Metformin—type 2 diabetes mellitus	4.52e-05	0.000391	CcSEcCtD
Rasagiline—Muscle spasms—Ramipril—type 2 diabetes mellitus	4.52e-05	0.000391	CcSEcCtD
Rasagiline—Confusional state—Losartan—type 2 diabetes mellitus	4.51e-05	0.00039	CcSEcCtD
Rasagiline—Feeling abnormal—Orlistat—type 2 diabetes mellitus	4.5e-05	0.00039	CcSEcCtD
Rasagiline—Dyspnoea—Metformin—type 2 diabetes mellitus	4.49e-05	0.000388	CcSEcCtD
Rasagiline—Somnolence—Metformin—type 2 diabetes mellitus	4.48e-05	0.000387	CcSEcCtD
Rasagiline—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.47e-05	0.000387	CcSEcCtD
Rasagiline—Infection—Losartan—type 2 diabetes mellitus	4.44e-05	0.000384	CcSEcCtD
Rasagiline—Hypotension—Irbesartan—type 2 diabetes mellitus	4.44e-05	0.000384	CcSEcCtD
Rasagiline—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.44e-05	0.000384	CcSEcCtD
Rasagiline—Dyspepsia—Metformin—type 2 diabetes mellitus	4.43e-05	0.000384	CcSEcCtD
Rasagiline—Tremor—Ramipril—type 2 diabetes mellitus	4.4e-05	0.000381	CcSEcCtD
Rasagiline—Shock—Losartan—type 2 diabetes mellitus	4.4e-05	0.000381	CcSEcCtD
Rasagiline—Urticaria—Valsartan—type 2 diabetes mellitus	4.39e-05	0.00038	CcSEcCtD
Rasagiline—Nervous system disorder—Losartan—type 2 diabetes mellitus	4.39e-05	0.00038	CcSEcCtD
Rasagiline—Decreased appetite—Metformin—type 2 diabetes mellitus	4.38e-05	0.000379	CcSEcCtD
Rasagiline—Abdominal pain—Valsartan—type 2 diabetes mellitus	4.37e-05	0.000378	CcSEcCtD
Rasagiline—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	4.36e-05	0.000377	CcSEcCtD
Rasagiline—Nausea—Bromocriptine—type 2 diabetes mellitus	4.36e-05	0.000377	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	4.35e-05	0.000376	CcSEcCtD
Rasagiline—Urticaria—Orlistat—type 2 diabetes mellitus	4.34e-05	0.000376	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.33e-05	0.000375	CcSEcCtD
Rasagiline—Hyperhidrosis—Losartan—type 2 diabetes mellitus	4.32e-05	0.000374	CcSEcCtD
Rasagiline—Body temperature increased—Orlistat—type 2 diabetes mellitus	4.32e-05	0.000374	CcSEcCtD
Rasagiline—Abdominal pain—Orlistat—type 2 diabetes mellitus	4.32e-05	0.000374	CcSEcCtD
Rasagiline—Asthenia—Gliclazide—type 2 diabetes mellitus	4.32e-05	0.000374	CcSEcCtD
Rasagiline—Agitation—Ramipril—type 2 diabetes mellitus	4.32e-05	0.000374	CcSEcCtD
Rasagiline—Constipation—Metformin—type 2 diabetes mellitus	4.31e-05	0.000373	CcSEcCtD
Rasagiline—Paraesthesia—Irbesartan—type 2 diabetes mellitus	4.27e-05	0.000369	CcSEcCtD
Rasagiline—Anorexia—Losartan—type 2 diabetes mellitus	4.26e-05	0.000369	CcSEcCtD
Rasagiline—Vomiting—Glyburide—type 2 diabetes mellitus	4.26e-05	0.000369	CcSEcCtD
Rasagiline—Pruritus—Gliclazide—type 2 diabetes mellitus	4.26e-05	0.000368	CcSEcCtD
Rasagiline—Malaise—Ramipril—type 2 diabetes mellitus	4.24e-05	0.000367	CcSEcCtD
Rasagiline—Dyspnoea—Irbesartan—type 2 diabetes mellitus	4.24e-05	0.000367	CcSEcCtD
Rasagiline—Rash—Glyburide—type 2 diabetes mellitus	4.23e-05	0.000366	CcSEcCtD
Rasagiline—Somnolence—Irbesartan—type 2 diabetes mellitus	4.23e-05	0.000366	CcSEcCtD
Rasagiline—Dermatitis—Glyburide—type 2 diabetes mellitus	4.22e-05	0.000365	CcSEcCtD
Rasagiline—Vertigo—Ramipril—type 2 diabetes mellitus	4.22e-05	0.000365	CcSEcCtD
Rasagiline—Syncope—Ramipril—type 2 diabetes mellitus	4.21e-05	0.000365	CcSEcCtD
Rasagiline—Leukopenia—Ramipril—type 2 diabetes mellitus	4.21e-05	0.000364	CcSEcCtD
Rasagiline—Headache—Glyburide—type 2 diabetes mellitus	4.2e-05	0.000363	CcSEcCtD
Rasagiline—Dyspepsia—Irbesartan—type 2 diabetes mellitus	4.18e-05	0.000362	CcSEcCtD
Rasagiline—Hypotension—Losartan—type 2 diabetes mellitus	4.18e-05	0.000362	CcSEcCtD
Rasagiline—Feeling abnormal—Metformin—type 2 diabetes mellitus	4.15e-05	0.000359	CcSEcCtD
Rasagiline—Decreased appetite—Irbesartan—type 2 diabetes mellitus	4.13e-05	0.000357	CcSEcCtD
Rasagiline—Loss of consciousness—Ramipril—type 2 diabetes mellitus	4.13e-05	0.000357	CcSEcCtD
Rasagiline—Diarrhoea—Gliclazide—type 2 diabetes mellitus	4.12e-05	0.000356	CcSEcCtD
Rasagiline—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	4.12e-05	0.000356	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	4.1e-05	0.000355	CcSEcCtD
Rasagiline—Cough—Ramipril—type 2 diabetes mellitus	4.1e-05	0.000355	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	4.08e-05	0.000353	CcSEcCtD
Rasagiline—Hypersensitivity—Valsartan—type 2 diabetes mellitus	4.07e-05	0.000353	CcSEcCtD
Rasagiline—Convulsion—Ramipril—type 2 diabetes mellitus	4.07e-05	0.000352	CcSEcCtD
Rasagiline—Constipation—Irbesartan—type 2 diabetes mellitus	4.06e-05	0.000352	CcSEcCtD
Rasagiline—Insomnia—Losartan—type 2 diabetes mellitus	4.05e-05	0.00035	CcSEcCtD
Rasagiline—Hypersensitivity—Orlistat—type 2 diabetes mellitus	4.03e-05	0.000348	CcSEcCtD
Rasagiline—Paraesthesia—Losartan—type 2 diabetes mellitus	4.02e-05	0.000347	CcSEcCtD
Rasagiline—Urticaria—Metformin—type 2 diabetes mellitus	4e-05	0.000346	CcSEcCtD
Rasagiline—Chest pain—Ramipril—type 2 diabetes mellitus	4e-05	0.000346	CcSEcCtD
Rasagiline—Arthralgia—Ramipril—type 2 diabetes mellitus	4e-05	0.000346	CcSEcCtD
Rasagiline—Dyspnoea—Losartan—type 2 diabetes mellitus	3.99e-05	0.000345	CcSEcCtD
Rasagiline—Anxiety—Ramipril—type 2 diabetes mellitus	3.99e-05	0.000345	CcSEcCtD
Rasagiline—Nausea—Glyburide—type 2 diabetes mellitus	3.98e-05	0.000345	CcSEcCtD
Rasagiline—Abdominal pain—Metformin—type 2 diabetes mellitus	3.98e-05	0.000344	CcSEcCtD
Rasagiline—Dizziness—Gliclazide—type 2 diabetes mellitus	3.98e-05	0.000344	CcSEcCtD
Rasagiline—Somnolence—Losartan—type 2 diabetes mellitus	3.98e-05	0.000344	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	3.97e-05	0.000344	CcSEcCtD
Rasagiline—Asthenia—Valsartan—type 2 diabetes mellitus	3.97e-05	0.000343	CcSEcCtD
Rasagiline—Discomfort—Ramipril—type 2 diabetes mellitus	3.95e-05	0.000342	CcSEcCtD
Rasagiline—Dyspepsia—Losartan—type 2 diabetes mellitus	3.94e-05	0.000341	CcSEcCtD
Rasagiline—Asthenia—Orlistat—type 2 diabetes mellitus	3.92e-05	0.000339	CcSEcCtD
Rasagiline—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	3.92e-05	0.000339	CcSEcCtD
Rasagiline—Pruritus—Valsartan—type 2 diabetes mellitus	3.91e-05	0.000339	CcSEcCtD
Rasagiline—Dry mouth—Ramipril—type 2 diabetes mellitus	3.91e-05	0.000339	CcSEcCtD
Rasagiline—Decreased appetite—Losartan—type 2 diabetes mellitus	3.89e-05	0.000336	CcSEcCtD
Rasagiline—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	3.89e-05	0.000336	CcSEcCtD
Rasagiline—Confusional state—Ramipril—type 2 diabetes mellitus	3.87e-05	0.000335	CcSEcCtD
Rasagiline—Pruritus—Orlistat—type 2 diabetes mellitus	3.87e-05	0.000335	CcSEcCtD
Rasagiline—Vomiting—Gliclazide—type 2 diabetes mellitus	3.83e-05	0.000331	CcSEcCtD
Rasagiline—Constipation—Losartan—type 2 diabetes mellitus	3.82e-05	0.000331	CcSEcCtD
Rasagiline—Rash—Gliclazide—type 2 diabetes mellitus	3.8e-05	0.000328	CcSEcCtD
Rasagiline—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.79e-05	0.000328	CcSEcCtD
Rasagiline—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.78e-05	0.000327	CcSEcCtD
Rasagiline—Urticaria—Irbesartan—type 2 diabetes mellitus	3.78e-05	0.000327	CcSEcCtD
Rasagiline—Shock—Ramipril—type 2 diabetes mellitus	3.77e-05	0.000326	CcSEcCtD
Rasagiline—Headache—Gliclazide—type 2 diabetes mellitus	3.77e-05	0.000326	CcSEcCtD
Rasagiline—Nervous system disorder—Ramipril—type 2 diabetes mellitus	3.76e-05	0.000325	CcSEcCtD
Rasagiline—Body temperature increased—Irbesartan—type 2 diabetes mellitus	3.76e-05	0.000325	CcSEcCtD
Rasagiline—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.76e-05	0.000325	CcSEcCtD
Rasagiline—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.74e-05	0.000324	CcSEcCtD
Rasagiline—Skin disorder—Ramipril—type 2 diabetes mellitus	3.73e-05	0.000322	CcSEcCtD
Rasagiline—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3.71e-05	0.000321	CcSEcCtD
Rasagiline—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.69e-05	0.000319	CcSEcCtD
Rasagiline—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.66e-05	0.000316	CcSEcCtD
Rasagiline—Dizziness—Valsartan—type 2 diabetes mellitus	3.66e-05	0.000316	CcSEcCtD
Rasagiline—Anorexia—Ramipril—type 2 diabetes mellitus	3.66e-05	0.000316	CcSEcCtD
Rasagiline—Dizziness—Orlistat—type 2 diabetes mellitus	3.61e-05	0.000313	CcSEcCtD
Rasagiline—Asthenia—Metformin—type 2 diabetes mellitus	3.61e-05	0.000313	CcSEcCtD
Rasagiline—Hypotension—Ramipril—type 2 diabetes mellitus	3.58e-05	0.00031	CcSEcCtD
Rasagiline—Nausea—Gliclazide—type 2 diabetes mellitus	3.58e-05	0.000309	CcSEcCtD
Rasagiline—Pruritus—Metformin—type 2 diabetes mellitus	3.56e-05	0.000308	CcSEcCtD
Rasagiline—Urticaria—Losartan—type 2 diabetes mellitus	3.55e-05	0.000307	CcSEcCtD
Rasagiline—Body temperature increased—Losartan—type 2 diabetes mellitus	3.54e-05	0.000306	CcSEcCtD
Rasagiline—Abdominal pain—Losartan—type 2 diabetes mellitus	3.54e-05	0.000306	CcSEcCtD
Rasagiline—Vomiting—Valsartan—type 2 diabetes mellitus	3.52e-05	0.000304	CcSEcCtD
Rasagiline—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.5e-05	0.000303	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.49e-05	0.000302	CcSEcCtD
Rasagiline—Rash—Valsartan—type 2 diabetes mellitus	3.49e-05	0.000302	CcSEcCtD
Rasagiline—Dermatitis—Valsartan—type 2 diabetes mellitus	3.48e-05	0.000301	CcSEcCtD
Rasagiline—Vomiting—Orlistat—type 2 diabetes mellitus	3.47e-05	0.000301	CcSEcCtD
Rasagiline—Insomnia—Ramipril—type 2 diabetes mellitus	3.47e-05	0.0003	CcSEcCtD
Rasagiline—Headache—Valsartan—type 2 diabetes mellitus	3.46e-05	0.0003	CcSEcCtD
Rasagiline—Diarrhoea—Metformin—type 2 diabetes mellitus	3.45e-05	0.000298	CcSEcCtD
Rasagiline—Rash—Orlistat—type 2 diabetes mellitus	3.45e-05	0.000298	CcSEcCtD
Rasagiline—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.44e-05	0.000298	CcSEcCtD
Rasagiline—Dermatitis—Orlistat—type 2 diabetes mellitus	3.44e-05	0.000298	CcSEcCtD
Rasagiline—Headache—Orlistat—type 2 diabetes mellitus	3.42e-05	0.000296	CcSEcCtD
Rasagiline—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.42e-05	0.000296	CcSEcCtD
Rasagiline—Asthenia—Irbesartan—type 2 diabetes mellitus	3.41e-05	0.000295	CcSEcCtD
Rasagiline—Somnolence—Ramipril—type 2 diabetes mellitus	3.41e-05	0.000295	CcSEcCtD
Rasagiline—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.38e-05	0.000292	CcSEcCtD
Rasagiline—Pruritus—Irbesartan—type 2 diabetes mellitus	3.36e-05	0.000291	CcSEcCtD
Rasagiline—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.33e-05	0.000288	CcSEcCtD
Rasagiline—Dizziness—Metformin—type 2 diabetes mellitus	3.33e-05	0.000288	CcSEcCtD
Rasagiline—MAOB—Metabolism—NCOA6—type 2 diabetes mellitus	3.33e-05	0.000608	CbGpPWpGaD
Rasagiline—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.31e-05	0.000286	CcSEcCtD
Rasagiline—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.3e-05	0.000285	CcSEcCtD
Rasagiline—Nausea—Valsartan—type 2 diabetes mellitus	3.29e-05	0.000284	CcSEcCtD
Rasagiline—BCL2—Focal Adhesion—SRC—type 2 diabetes mellitus	3.28e-05	0.000601	CbGpPWpGaD
Rasagiline—Constipation—Ramipril—type 2 diabetes mellitus	3.28e-05	0.000284	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	3.27e-05	0.000598	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—HSD11B1—type 2 diabetes mellitus	3.27e-05	0.000598	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—UCP2—type 2 diabetes mellitus	3.27e-05	0.000598	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—UCP3—type 2 diabetes mellitus	3.27e-05	0.000598	CbGpPWpGaD
Rasagiline—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.25e-05	0.000281	CcSEcCtD
Rasagiline—Nausea—Orlistat—type 2 diabetes mellitus	3.25e-05	0.000281	CcSEcCtD
Rasagiline—BCL2—Apoptosis—TNF—type 2 diabetes mellitus	3.23e-05	0.00059	CbGpPWpGaD
Rasagiline—Asthenia—Losartan—type 2 diabetes mellitus	3.21e-05	0.000278	CcSEcCtD
Rasagiline—Vomiting—Metformin—type 2 diabetes mellitus	3.2e-05	0.000277	CcSEcCtD
Rasagiline—BCL2—Focal Adhesion—VEGFA—type 2 diabetes mellitus	3.2e-05	0.000585	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	3.19e-05	0.000583	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—AKT1—type 2 diabetes mellitus	3.18e-05	0.000582	CbGpPWpGaD
Rasagiline—CYP1A2—Phase II conjugation—GSTM1—type 2 diabetes mellitus	3.18e-05	0.000581	CbGpPWpGaD
Rasagiline—Rash—Metformin—type 2 diabetes mellitus	3.18e-05	0.000275	CcSEcCtD
Rasagiline—Dermatitis—Metformin—type 2 diabetes mellitus	3.17e-05	0.000274	CcSEcCtD
Rasagiline—Pruritus—Losartan—type 2 diabetes mellitus	3.16e-05	0.000274	CcSEcCtD
Rasagiline—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.16e-05	0.000273	CcSEcCtD
Rasagiline—Headache—Metformin—type 2 diabetes mellitus	3.16e-05	0.000273	CcSEcCtD
Rasagiline—Dizziness—Irbesartan—type 2 diabetes mellitus	3.14e-05	0.000272	CcSEcCtD
Rasagiline—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.14e-05	0.000271	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—RELA—type 2 diabetes mellitus	3.1e-05	0.000567	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PCK1—type 2 diabetes mellitus	3.07e-05	0.000562	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—MTR—type 2 diabetes mellitus	3.07e-05	0.000561	CbGpPWpGaD
Rasagiline—Diarrhoea—Losartan—type 2 diabetes mellitus	3.06e-05	0.000265	CcSEcCtD
Rasagiline—Urticaria—Ramipril—type 2 diabetes mellitus	3.05e-05	0.000264	CcSEcCtD
Rasagiline—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.03e-05	0.000262	CcSEcCtD
Rasagiline—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.03e-05	0.000262	CcSEcCtD
Rasagiline—Vomiting—Irbesartan—type 2 diabetes mellitus	3.02e-05	0.000261	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—type 2 diabetes mellitus	3.01e-05	0.00055	CbGpPWpGaD
Rasagiline—Rash—Irbesartan—type 2 diabetes mellitus	3e-05	0.000259	CcSEcCtD
Rasagiline—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.99e-05	0.000259	CcSEcCtD
Rasagiline—Nausea—Metformin—type 2 diabetes mellitus	2.99e-05	0.000259	CcSEcCtD
Rasagiline—Headache—Irbesartan—type 2 diabetes mellitus	2.98e-05	0.000258	CcSEcCtD
Rasagiline—CYP1A2—Biological oxidations—CYP11A1—type 2 diabetes mellitus	2.97e-05	0.000543	CbGpPWpGaD
Rasagiline—Dizziness—Losartan—type 2 diabetes mellitus	2.96e-05	0.000256	CcSEcCtD
Rasagiline—CYP1A2—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	2.93e-05	0.000536	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	2.92e-05	0.000535	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—EGFR—type 2 diabetes mellitus	2.88e-05	0.000527	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—HK1—type 2 diabetes mellitus	2.88e-05	0.000527	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	2.87e-05	0.000524	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—AGER—type 2 diabetes mellitus	2.86e-05	0.000523	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—ADCY5—type 2 diabetes mellitus	2.85e-05	0.000521	CbGpPWpGaD
Rasagiline—Vomiting—Losartan—type 2 diabetes mellitus	2.84e-05	0.000246	CcSEcCtD
Rasagiline—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.83e-05	0.000244	CcSEcCtD
Rasagiline—Nausea—Irbesartan—type 2 diabetes mellitus	2.82e-05	0.000244	CcSEcCtD
Rasagiline—Rash—Losartan—type 2 diabetes mellitus	2.82e-05	0.000244	CcSEcCtD
Rasagiline—Dermatitis—Losartan—type 2 diabetes mellitus	2.82e-05	0.000244	CcSEcCtD
Rasagiline—CYP1A2—Arachidonic acid metabolism—PTGS2—type 2 diabetes mellitus	2.81e-05	0.000515	CbGpPWpGaD
Rasagiline—Headache—Losartan—type 2 diabetes mellitus	2.8e-05	0.000242	CcSEcCtD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	2.78e-05	0.000509	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—HSD3B2—type 2 diabetes mellitus	2.78e-05	0.000509	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—LPA—type 2 diabetes mellitus	2.78e-05	0.000509	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—KCNJ11—type 2 diabetes mellitus	2.78e-05	0.000509	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GCKR—type 2 diabetes mellitus	2.78e-05	0.000509	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CD36—type 2 diabetes mellitus	2.76e-05	0.000505	CbGpPWpGaD
Rasagiline—Asthenia—Ramipril—type 2 diabetes mellitus	2.75e-05	0.000238	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	2.73e-05	0.000499	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—PPP2CA—type 2 diabetes mellitus	2.73e-05	0.000499	CbGpPWpGaD
Rasagiline—Pruritus—Ramipril—type 2 diabetes mellitus	2.71e-05	0.000235	CcSEcCtD
Rasagiline—MAOB—Metabolism—ALDOB—type 2 diabetes mellitus	2.67e-05	0.000488	CbGpPWpGaD
Rasagiline—Nausea—Losartan—type 2 diabetes mellitus	2.66e-05	0.00023	CcSEcCtD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	2.64e-05	0.000482	CbGpPWpGaD
Rasagiline—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.62e-05	0.000227	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—C3—type 2 diabetes mellitus	2.62e-05	0.000479	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—type 2 diabetes mellitus	2.61e-05	0.000478	CbGpPWpGaD
Rasagiline—Dizziness—Ramipril—type 2 diabetes mellitus	2.54e-05	0.000219	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—BCL2L1—type 2 diabetes mellitus	2.51e-05	0.000458	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—IRS2—type 2 diabetes mellitus	2.49e-05	0.000456	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CRP—type 2 diabetes mellitus	2.49e-05	0.000456	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PSMD6—type 2 diabetes mellitus	2.49e-05	0.000455	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GLP1R—type 2 diabetes mellitus	2.48e-05	0.000453	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—AKT1—type 2 diabetes mellitus	2.45e-05	0.000449	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—CYP2E1—type 2 diabetes mellitus	2.45e-05	0.000449	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CALM1—type 2 diabetes mellitus	2.45e-05	0.000447	CbGpPWpGaD
Rasagiline—Vomiting—Ramipril—type 2 diabetes mellitus	2.44e-05	0.000211	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—SRC—type 2 diabetes mellitus	2.43e-05	0.000445	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—type 2 diabetes mellitus	2.43e-05	0.000445	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	2.42e-05	0.000442	CbGpPWpGaD
Rasagiline—Rash—Ramipril—type 2 diabetes mellitus	2.42e-05	0.000209	CcSEcCtD
Rasagiline—Dermatitis—Ramipril—type 2 diabetes mellitus	2.42e-05	0.000209	CcSEcCtD
Rasagiline—BCL2—Immune System—CYBA—type 2 diabetes mellitus	2.41e-05	0.000441	CbGpPWpGaD
Rasagiline—Headache—Ramipril—type 2 diabetes mellitus	2.4e-05	0.000208	CcSEcCtD
Rasagiline—BCL2—Apoptosis—AKT1—type 2 diabetes mellitus	2.4e-05	0.000439	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—type 2 diabetes mellitus	2.37e-05	0.000434	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—CYP3A4—type 2 diabetes mellitus	2.36e-05	0.000433	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	2.33e-05	0.000427	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—SLC2A2—type 2 diabetes mellitus	2.31e-05	0.000423	CbGpPWpGaD
Rasagiline—Nausea—Ramipril—type 2 diabetes mellitus	2.28e-05	0.000197	CcSEcCtD
Rasagiline—MAOB—Metabolism—MTR—type 2 diabetes mellitus	2.27e-05	0.000415	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CPT1A—type 2 diabetes mellitus	2.27e-05	0.000415	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—NAMPT—type 2 diabetes mellitus	2.22e-05	0.000407	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—HBA1—type 2 diabetes mellitus	2.21e-05	0.000404	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—LIPC—type 2 diabetes mellitus	2.21e-05	0.000404	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GCK—type 2 diabetes mellitus	2.21e-05	0.000404	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CYP11A1—type 2 diabetes mellitus	2.2e-05	0.000402	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—type 2 diabetes mellitus	2.18e-05	0.000398	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—IRS1—type 2 diabetes mellitus	2.17e-05	0.000398	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PTPN1—type 2 diabetes mellitus	2.16e-05	0.000395	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—SLC9A1—type 2 diabetes mellitus	2.16e-05	0.000394	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—type 2 diabetes mellitus	2.13e-05	0.00039	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—type 2 diabetes mellitus	2.13e-05	0.00039	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CETP—type 2 diabetes mellitus	2.13e-05	0.00039	CbGpPWpGaD
Rasagiline—BCL2—Immune System—RASGRP1—type 2 diabetes mellitus	2.12e-05	0.000388	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	2.05e-05	0.000375	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CASP8—type 2 diabetes mellitus	2.05e-05	0.000375	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—AKT1—type 2 diabetes mellitus	2.04e-05	0.000373	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	2.03e-05	0.000372	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—type 2 diabetes mellitus	2.03e-05	0.000372	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—type 2 diabetes mellitus	2.03e-05	0.000372	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—AKT2—type 2 diabetes mellitus	2.01e-05	0.000368	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	2e-05	0.000366	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—SREBF1—type 2 diabetes mellitus	1.98e-05	0.000362	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—SNAP25—type 2 diabetes mellitus	1.98e-05	0.000362	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PSMD6—type 2 diabetes mellitus	1.98e-05	0.000362	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CTGF—type 2 diabetes mellitus	1.94e-05	0.000356	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—HMGCR—type 2 diabetes mellitus	1.93e-05	0.000353	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	1.91e-05	0.000349	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	1.91e-05	0.000349	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	1.91e-05	0.000349	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ADRA2A—type 2 diabetes mellitus	1.89e-05	0.000345	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—GSTM1—type 2 diabetes mellitus	1.86e-05	0.00034	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	1.83e-05	0.000335	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—PIK3R1—type 2 diabetes mellitus	1.83e-05	0.000334	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CYP2E1—type 2 diabetes mellitus	1.81e-05	0.000331	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CYP1A2—type 2 diabetes mellitus	1.79e-05	0.000328	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—SLC2A1—type 2 diabetes mellitus	1.79e-05	0.000328	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CYP3A4—type 2 diabetes mellitus	1.75e-05	0.00032	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	1.73e-05	0.000316	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—RELA—type 2 diabetes mellitus	1.72e-05	0.000314	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GCG—type 2 diabetes mellitus	1.72e-05	0.000314	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—SLC2A4—type 2 diabetes mellitus	1.72e-05	0.000314	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	1.7e-05	0.000311	CbGpPWpGaD
Rasagiline—BCL2—Immune System—AGER—type 2 diabetes mellitus	1.66e-05	0.000304	CbGpPWpGaD
Rasagiline—BCL2—Immune System—ADCY5—type 2 diabetes mellitus	1.66e-05	0.000303	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CD36—type 2 diabetes mellitus	1.61e-05	0.000294	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PPP2CA—type 2 diabetes mellitus	1.59e-05	0.000291	CbGpPWpGaD
Rasagiline—BCL2—Immune System—C3—type 2 diabetes mellitus	1.52e-05	0.000279	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.48e-05	0.000271	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GNB3—type 2 diabetes mellitus	1.48e-05	0.000271	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—HMOX1—type 2 diabetes mellitus	1.47e-05	0.00027	CbGpPWpGaD
Rasagiline—BCL2—Immune System—BCL2L1—type 2 diabetes mellitus	1.46e-05	0.000267	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CAT—type 2 diabetes mellitus	1.45e-05	0.000266	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CRP—type 2 diabetes mellitus	1.45e-05	0.000265	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IRS2—type 2 diabetes mellitus	1.45e-05	0.000265	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—NFKB1—type 2 diabetes mellitus	1.45e-05	0.000265	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	1.44e-05	0.000264	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	1.44e-05	0.000264	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CALM1—type 2 diabetes mellitus	1.42e-05	0.000261	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—BHMT—type 2 diabetes mellitus	1.42e-05	0.000259	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—APOB—type 2 diabetes mellitus	1.41e-05	0.000258	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GSTM1—type 2 diabetes mellitus	1.37e-05	0.000251	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—SRC—type 2 diabetes mellitus	1.35e-05	0.000247	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—LPL—type 2 diabetes mellitus	1.35e-05	0.000247	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PRKCB—type 2 diabetes mellitus	1.34e-05	0.000245	CbGpPWpGaD
Rasagiline—BCL2—Immune System—ICAM1—type 2 diabetes mellitus	1.33e-05	0.000244	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ADCY5—type 2 diabetes mellitus	1.32e-05	0.000241	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GPX1—type 2 diabetes mellitus	1.32e-05	0.000241	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CD36—type 2 diabetes mellitus	1.28e-05	0.000234	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IRS1—type 2 diabetes mellitus	1.27e-05	0.000232	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PPP2CA—type 2 diabetes mellitus	1.26e-05	0.000231	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—AANAT—type 2 diabetes mellitus	1.24e-05	0.000227	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PTGDS—type 2 diabetes mellitus	1.24e-05	0.000227	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—MTHFR—type 2 diabetes mellitus	1.21e-05	0.000222	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CASP8—type 2 diabetes mellitus	1.19e-05	0.000218	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PPARA—type 2 diabetes mellitus	1.19e-05	0.000218	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—EGFR—type 2 diabetes mellitus	1.18e-05	0.000217	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	1.18e-05	0.000215	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GPD2—type 2 diabetes mellitus	1.17e-05	0.000215	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CDO1—type 2 diabetes mellitus	1.17e-05	0.000215	CbGpPWpGaD
Rasagiline—BCL2—Immune System—AKT2—type 2 diabetes mellitus	1.17e-05	0.000214	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—AGT—type 2 diabetes mellitus	1.15e-05	0.000211	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	1.15e-05	0.00021	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	1.14e-05	0.000209	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CALM1—type 2 diabetes mellitus	1.13e-05	0.000207	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—APOE—type 2 diabetes mellitus	1.13e-05	0.000207	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—AK1—type 2 diabetes mellitus	1.12e-05	0.000205	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—APOA1—type 2 diabetes mellitus	1.12e-05	0.000204	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	1.11e-05	0.000203	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PIK3R1—type 2 diabetes mellitus	1.06e-05	0.000195	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—MAT1A—type 2 diabetes mellitus	1.03e-05	0.000189	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SLC5A4—type 2 diabetes mellitus	1.03e-05	0.000189	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	1.03e-05	0.000188	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	1.01e-05	0.000185	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	1e-05	0.000183	CbGpPWpGaD
Rasagiline—BCL2—Immune System—RELA—type 2 diabetes mellitus	1e-05	0.000183	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PPP1R3C—type 2 diabetes mellitus	9.99e-06	0.000183	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ENPP1—type 2 diabetes mellitus	9.99e-06	0.000183	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—G6PC—type 2 diabetes mellitus	9.99e-06	0.000183	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—HBA2—type 2 diabetes mellitus	9.99e-06	0.000183	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ND1—type 2 diabetes mellitus	9.99e-06	0.000183	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PPARG—type 2 diabetes mellitus	9.84e-06	0.00018	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GCGR—type 2 diabetes mellitus	9.67e-06	0.000177	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—INS—type 2 diabetes mellitus	9.65e-06	0.000177	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CYTB—type 2 diabetes mellitus	9.13e-06	0.000167	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—OXCT1—type 2 diabetes mellitus	9.13e-06	0.000167	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—IL6—type 2 diabetes mellitus	9.1e-06	0.000166	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SRD5A1—type 2 diabetes mellitus	8.9e-06	0.000163	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ALB—type 2 diabetes mellitus	8.85e-06	0.000162	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—HSD17B3—type 2 diabetes mellitus	8.49e-06	0.000155	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—STAR—type 2 diabetes mellitus	8.49e-06	0.000155	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ACACA—type 2 diabetes mellitus	8.49e-06	0.000155	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PIK3R1—type 2 diabetes mellitus	8.46e-06	0.000155	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—NOS3—type 2 diabetes mellitus	8.46e-06	0.000155	CbGpPWpGaD
Rasagiline—BCL2—Immune System—NFKB1—type 2 diabetes mellitus	8.44e-06	0.000154	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—AKT1—type 2 diabetes mellitus	8.39e-06	0.000154	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CBS—type 2 diabetes mellitus	8.14e-06	0.000149	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ABCC8—type 2 diabetes mellitus	8.14e-06	0.000149	CbGpPWpGaD
Rasagiline—BCL2—Immune System—SRC—type 2 diabetes mellitus	7.87e-06	0.000144	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SLC5A2—type 2 diabetes mellitus	7.84e-06	0.000143	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—COX2—type 2 diabetes mellitus	7.84e-06	0.000143	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PTGS2—type 2 diabetes mellitus	7.74e-06	0.000142	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	7.7e-06	0.000141	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	7.69e-06	0.000141	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	7.57e-06	0.000138	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	7.57e-06	0.000138	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	7.57e-06	0.000138	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	7.34e-06	0.000134	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	7.11e-06	0.00013	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	7e-06	0.000128	CbGpPWpGaD
Rasagiline—BCL2—Immune System—EGFR—type 2 diabetes mellitus	6.89e-06	0.000126	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	6.83e-06	0.000125	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	6.66e-06	0.000122	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	6.66e-06	0.000122	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	6.43e-06	0.000118	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	6.43e-06	0.000118	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	6.43e-06	0.000118	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	6.43e-06	0.000118	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	6.19e-06	0.000113	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	6.17e-06	0.000113	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	5.99e-06	0.00011	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	5.87e-06	0.000107	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	5.8e-06	0.000106	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	5.73e-06	0.000105	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	5.35e-06	9.79e-05	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL6—type 2 diabetes mellitus	5.3e-06	9.69e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	5.25e-06	9.6e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	5.25e-06	9.6e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	5.14e-06	9.41e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.11e-06	9.36e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	5.11e-06	9.35e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	5.11e-06	9.35e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	5.11e-06	9.35e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	5.08e-06	9.29e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	4.99e-06	9.13e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	4.93e-06	9.02e-05	CbGpPWpGaD
Rasagiline—BCL2—Immune System—AKT1—type 2 diabetes mellitus	4.89e-06	8.94e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.6e-06	8.41e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	4.58e-06	8.39e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	4.58e-06	8.39e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	4.58e-06	8.39e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	4.5e-06	8.23e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	4.46e-06	8.16e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.4e-06	8.05e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	4.36e-06	7.98e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	4.19e-06	7.67e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	4.15e-06	7.59e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	4.04e-06	7.4e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.02e-06	7.36e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	3.98e-06	7.27e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	3.98e-06	7.27e-05	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—AKT1—type 2 diabetes mellitus	3.89e-06	7.12e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.43e-06	6.27e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	3.43e-06	6.27e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.41e-06	6.24e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	3.37e-06	6.16e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	3.27e-06	5.98e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	3.18e-06	5.81e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	3.12e-06	5.71e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	3.05e-06	5.59e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	3.04e-06	5.57e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.96e-06	5.42e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.93e-06	5.35e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.81e-06	5.14e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.76e-06	5.04e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.67e-06	4.88e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.62e-06	4.8e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.61e-06	4.78e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.58e-06	4.73e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.28e-06	4.17e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	2.23e-06	4.09e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	2.05e-06	3.75e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.96e-06	3.58e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.96e-06	3.58e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.79e-06	3.28e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	9e-07	1.65e-05	CbGpPWpGaD
